Literature DB >> 17244160

Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.

Erna Van Hoeyveld1, Ping-Xia Zhang, Kris De Boeck, Ramsay Fuleihan, Xavier Bossuyt.   

Abstract

Hyper-immunoglobulin M (IgM) syndrome (HIGM) is a rare primary immunodeficiency characterized by elevated or normal IgM and absent or markedly decreased amounts of IgG, IgA and IgE. The X-linked form (HIGM1) is the most common type and is caused by mutations in the gene for CD40L, a T-cell surface molecule required for T-cell driven immunoglobulin class switching by B cells. In the present study we have identified a patient with X-linked hyper-IgM who failed to express CD40L on the cell surface of CD4(+) T lymphocytes. Sequence analysis of CD40L genomic DNA showed no mutations. CD40L mRNA was absent and sequence analysis of the CD40L promotor revealed a mutation at position -123 from the transcription start site. The mutation in the promotor region likely contributed to the decreased transcription as demonstrated by a luciferase reporter assay.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244160      PMCID: PMC2265910          DOI: 10.1111/j.1365-2567.2006.02520.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  Clinical spectrum of X-linked hyper-IgM syndrome.

Authors:  J Levy; T Espanol-Boren; C Thomas; A Fischer; P Tovo; P Bordigoni; I Resnick; A Fasth; M Baer; L Gomez; E A Sanders; M D Tabone; D Plantaz; A Etzioni; V Monafo; M Abinun; L Hammarstrom; T Abrahamsen; A Jones; A Finn; T Klemola; E DeVries; O Sanal; M C Peitsch; L D Notarangelo
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

2.  Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM.

Authors:  R Fuleihan; N Ramesh; R Loh; H Jabara; R S Rosen; T Chatila; S M Fu; I Stamenkovic; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

3.  Transcriptional activity of the distal CD40 ligand promoter.

Authors:  F M Lobo; S Xu; C Lee; R L Fuleihan
Journal:  Biochem Biophys Res Commun       Date:  2000-12-09       Impact factor: 3.575

4.  The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.

Authors:  Jerry A Winkelstein; Mary C Marino; Hans Ochs; Ramsey Fuleihan; Paul R Scholl; Raif Geha; E Richard Stiehm; Mary Ellen Conley
Journal:  Medicine (Baltimore)       Date:  2003-11       Impact factor: 1.889

5.  CD40L association with protection from severe malaria.

Authors:  P Sabeti; S Usen; S Farhadian; M Jallow; T Doherty; M Newport; M Pinder; R Ward; D Kwiatkowski
Journal:  Genes Immun       Date:  2002-08       Impact factor: 2.676

6.  Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome.

Authors:  M Shimadzu; H Nunoi; H Terasaki; R Ninomiya; M Iwata; S Kanegasaka; I Matsuda
Journal:  Biochim Biophys Acta       Date:  1995-01-02

7.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

8.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.

Authors:  U Korthäuer; D Graf; H W Mages; F Brière; M Padayachee; S Malcolm; A G Ugazio; L D Notarangelo; R J Levinsky; R A Kroczek
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

9.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.

Authors:  A Aruffo; M Farrington; D Hollenbaugh; X Li; A Milatovich; S Nonoyama; J Bajorath; L S Grosmaire; R Stenkamp; M Neubauer
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

10.  Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa.

Authors:  Sarah J Campbell; Pardis Sabeti; Katherine Fielding; Jackson Sillah; Boubacar Bah; Per Gustafson; Kebba Manneh; Ida Lisse; Giorgio Sirugo; Richard Bellamy; Steve Bennett; Peter Aaby; Keith P W J McAdam; Oumou Bah-Sow; Christian Lienhardt; Adrian V S Hill
Journal:  Immunogenetics       Date:  2003-08-29       Impact factor: 2.846

View more
  5 in total

1.  Clinical and molecular features of X-linked hyper IgM syndrome - An experience from North India.

Authors:  Amit Rawat; Babu Mathew; Vignesh Pandiarajan; Ankur Jindal; Madhubala Sharma; Deepti Suri; Anju Gupta; Shubham Goel; Adil Karim; Biman Saikia; Ranjana W Minz; Kohsuke Imai; Shigeaki Nonoyama; Osamu Ohara; Silvia Clara Giliani; Luigi D Notarangelo; Koon-Wing Chan; Yu-Lung Lau; Surjit Singh
Journal:  Clin Immunol       Date:  2018-07-25       Impact factor: 3.969

Review 2.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

3.  Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis.

Authors:  Ana Lleo; Jieyue Liao; Pietro Invernizzi; Ming Zhao; Francesca Bernuzzi; Le Ma; Gaetana Lanzi; Aftab A Ansari; Ross L Coppel; Peng Zhang; Yijun Li; Zhiguang Zhou; Qianjin Lu; M Eric Gershwin
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

Review 4.  Autoimmunity in hyper-IgM syndrome.

Authors:  Adriana A Jesus; Alberto J S Duarte; João B Oliveira
Journal:  J Clin Immunol       Date:  2008-02-02       Impact factor: 8.317

5.  Clinical features and genetic analysis of 20 Chinese patients with X-linked hyper-IgM syndrome.

Authors:  Lin-Lin Wang; Wei Zhou; Wei Zhao; Zhi-Qing Tian; Wei-Fan Wang; Xiao-Fang Wang; Tong-Xin Chen
Journal:  J Immunol Res       Date:  2014-08-20       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.